Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.
Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as a treatment for type 2 diabetes with associated obesity.